HomepageBlogEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine Blog IndustryEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine admin Posted on August 14, 2023 Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed……Please subscribe to read the full story.Author admin View all posts Post navigationPrevious PostMitsubishi Chemical to Mass-Produce GaN Substrates for More Energy-Efficient Vehicles, Devices Next PostJSR to Boost Production Capacity for Advanced Semiconductor PhotoresistsYou Might Also Like BlogInternational Market Prices Surge for PVC admin August 14, 2023 BlogMitsubishi Chemical Holdings Targets End of Fiscal 2022 for BN Sheet Commercialization admin August 14, 2023 BlogOji Holdings Develops Strong Biodegradable Resin by Incorporating Cellulose admin August 14, 2023 BlogInterview: Namasindo Plas CEO Yanto Widodo Discusses Rise Around, Future With Recycled PET admin August 14, 2023
BlogMitsubishi Chemical Holdings Targets End of Fiscal 2022 for BN Sheet Commercialization admin August 14, 2023
BlogOji Holdings Develops Strong Biodegradable Resin by Incorporating Cellulose admin August 14, 2023
BlogInterview: Namasindo Plas CEO Yanto Widodo Discusses Rise Around, Future With Recycled PET admin August 14, 2023
NewsChina Siaga: Ketika Negeri Tirai Bambu Bersiap Menghadapi Ketidakpastian Dunia Bagus Saputra March 16, 2026